Cascades Analytics is a research and advisory platform dedicated to understanding the science, strategy, and development of psychedelic and neuroplastogen therapeutics.
The platform was founded in 2024 by Alexandre Stipanovich, a neuropsychopharmacology researcher and industry analyst based in New York. Alexandre completed his PhD at Pierre and Marie Curie University Paris VI, where his thesis work was published in Nature. He subsequently conducted postdoctoral research at Yale Medical School in the laboratory of Pr. Angus Nairn, and at Rockefeller University in the laboratory of Nobel Laureate Paul Greengard, studying signaling pathways involved in neuroplasticity and psychiatric drug action.
Over the past several years, Alexandre has focused on the emerging field of psychedelic and neuroplastogen therapeutics, where advances in receptor pharmacology, neural plasticity, and drug design are opening new approaches to treating mental health disorders.
Over the past several years, Alexandre has focused on the emerging field of psychedelic and neuroplastogen therapeutics, where advances in receptor pharmacology, neural plasticity, and drug design are opening new approaches to treating mental health disorders.
Through Cascades Analytics, he bridges academic neuroscience, biotech development, and investment decision-making, providing clear analysis of how compounds move from receptor pharmacology to clinical trials and ultimately to patients.